These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 28576421)
1. [Impact of Gleason score on biochemical recurrence free survival after radical prostatectomy with positive surgical margins]. Roux V; Eyraud R; Brureau L; Gourtaud G; Senechal C; Fofana M; Blanchet P Prog Urol; 2017; 27(8-9):467-473. PubMed ID: 28576421 [TBL] [Abstract][Full Text] [Related]
2. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
3. Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies). Brureau L; Emeville E; Multigner L; Blanchet P Prog Urol; 2018 Jun; 28(8-9):442-449. PubMed ID: 29789237 [TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968 [TBL] [Abstract][Full Text] [Related]
5. Biochemical recurrence rates are similar for pT2-positive surgical margins and pT3a. Leite KR; Hartmann C; Reis ST; Viana N; Dall'Oglio MF; Sant'Anna AC; Nesrallah A; Nesrallah L; Antunes AA; Camara-Lopes LH; Srougi M Int Braz J Urol; 2014; 40(2):146-53. PubMed ID: 24856481 [TBL] [Abstract][Full Text] [Related]
6. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924 [TBL] [Abstract][Full Text] [Related]
7. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy. Hashimoto T; Nakashima J; Inoue R; Komori O; Yamaguchi Y; Kashima T; Satake N; Nakagami Y; Namiki K; Nagao T; Ohno Y Int J Clin Oncol; 2020 Feb; 25(2):377-383. PubMed ID: 31673831 [TBL] [Abstract][Full Text] [Related]
8. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502 [TBL] [Abstract][Full Text] [Related]
9. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536 [TBL] [Abstract][Full Text] [Related]
10. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy. Rodriguez-Covarrubias F; Larre S; De La Taille A; Abbou CC; Salomon L BJU Int; 2008 Feb; 101(3):305-7. PubMed ID: 17941921 [TBL] [Abstract][Full Text] [Related]
11. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence. Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829 [TBL] [Abstract][Full Text] [Related]
12. Predictive factors associated with biochemical recurrence following radical prostatectomy for pathological T2 prostate cancer with negative surgical margins. Aoun F; Albisinni S; Henriet B; Tombal B; Van Velthoven R; Roumeguère T Scand J Urol; 2017 Feb; 51(1):20-26. PubMed ID: 27910728 [TBL] [Abstract][Full Text] [Related]
13. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology. Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577 [TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome. De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296 [TBL] [Abstract][Full Text] [Related]
15. Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer. Huang JG; Pedersen J; Hong MK; Harewood LM; Peters J; Costello AJ; Hovens CM; Corcoran NM BJU Int; 2013 May; 111(6):921-7. PubMed ID: 23350712 [TBL] [Abstract][Full Text] [Related]
16. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. Guillonneau B; el-Fettouh H; Baumert H; Cathelineau X; Doublet JD; Fromont G; Vallancien G J Urol; 2003 Apr; 169(4):1261-6. PubMed ID: 12629339 [TBL] [Abstract][Full Text] [Related]
17. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Marks RA; Koch MO; Lopez-Beltran A; Montironi R; Juliar BE; Cheng L Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720 [TBL] [Abstract][Full Text] [Related]
18. Positive surgical margins and biochemical recurrence following minimally-invasive radical prostatectomy - An analysis of outcomes from a UK tertiary referral centre. Sachdeva A; Veeratterapillay R; Voysey A; Kelly K; Johnson MI; Aning J; Soomro NA BMC Urol; 2017 Oct; 17(1):91. PubMed ID: 28969608 [TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens. Algarra R; Barba J; Merino I; Tienza A; Tolosa E; Robles JE; Zudaire J Actas Urol Esp; 2015 Apr; 39(3):144-53. PubMed ID: 24996780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]